Intensive lifestyle changes for reversal of coronary heart disease

JAMA

Volumn 280, Issue 23, 1998, Pages 2001-2007

  Ornish, Dean ^a,f   Scherwitz, Larry W ^a   Billings, James H ^a   Lance Gould, K ^a   Merritt, Terri A ^b   Sparler, Stephen ^a   Armstrong, William T ^c   Ports, Thomas A ^d   Kirkeeide, Richard L ^d   Hogeboom, Charissa ^e   Brand, Richard J ^f  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b Department of Medicine ^*  (United States)

^c Cardiac Catheterization Laboratory   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f Preventive Medicine Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; DIETARY INTAKE; EXERCISE; FEMALE; GROUP THERAPY; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MALE; MENTAL STRESS; PRIORITY JOURNAL; RISK FACTOR; SMOKING CESSATION; TRAINING;

EID: 0032539162     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.23.2001     Document Type: Article

References (32)

1. Ornish DM, Scherwitz L W, Doody RS, et al. Effects of stress management training and dietary changes in treating ischemic heart disease. JAMA. 1983;249:54-59.
2. Ornish DM, Gotto AM, Miller RR, et al. Effects of a vegetarian diet and selected yoga techniques in the treatment of coronary heart disease [abstract]. Clin Res. 1979;27:720A.
3. Ornish DM, Brown SE, Schenvitz LW, et al. Can lifestyle changes reverse coronary atherosclerosis? The Lifestyle Heart Trial. Lancet. 1990;336:129-133.
4. Gould KL, Ornish D, Kirkeeide R, et al. Improved stenosis geometry by quantitative coronary arteriography after vigorous risk factor modification. Am J Cardiol. 1992;69:845-853.
5. Gould KL, Ornish D, Schenvitz L, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA. 1995;74:894-901.
6. Stuff JE, Garza C, Smith EO, et al. A comparison of dietary methods in nutritional studies. Am J Clin Nutr. 1983;37:300-306.
7. Ornish D. Reversing Heart Disease. New York, NY: Ballantine Books; 1992.
8. Billings J, Scherwitz L, Sullivan R, Ornish D. Group support therapy in the Lifestyle Heart Trial. In: Scheldt S, Allan R, eds. Heart and Mind: The Emergence of Cardiac Psychology. Washington, DC: American Psychological Association; 1996: 233-253.
9. Moyers B. Changing life habits: a conversation with Dean Ornish. In: Healing and the Mind. New York, NY: Doubleday & Co Inc; 1993.
10. American College of Sports Medicine. Guidelines for Exercise Testing and Prescription. Philadelphia, Pa: Lea & Febiger; 1986.
11. SAS Institute Inc. SAS/STAT, Version 6.08: Changes and Enhancements, SAS Technical Report P-229. Cary, NC: SAS Institute; 1992.
12. Ornish D. More on low-fat diets. N Engl J Med. 1998;338:1623-1624.
13. Brown EG, Alberts JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990 23:1289-1298.
14. Jukema J W, Bruschke AVG, Van Boven AJ, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. Circulation. 1995; 912528-2540.
15. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet. 1994;344:1383-1389.
16. Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. Circulation. 1994;89:975-990.
17. Via JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-497.
18. Harrison DG, Armstrong ML, Freimann PC, et al. Restoration of endothelium-dependent arterial relaxation by dietary treatment of atherosclerosis. Circulation. 1987;80:1808-1811.
19. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med l995;333: 1301-1307.
20. Hunninghake DB, Stein E A, Dujovne CA, et al. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med. 1993;328:1213-1219.
21. Stefanick ML, Mackey S, Sheehan M, et al. Effects of diet and exercise in men and postmenopausal women with low levels of HDL-C and high levels of LDL cholesterol. N Engl J Med. 1998;339:12-20.
22. Katar. MB, Grundy SM, Willett WC. Should a low-fat, high-carbohydrate diet be recommended for everyone? beyond low-fat diets. NEnglJMed. 1997; 337:563-567.
23. Lichtenstein AH, Van Horn L. Very low fat diets: AHA Science Advisory. Circulation. 1998;98: 935-939.
24. Brinton E A, Eisenberg S, Breslow JL. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. J Clin Invest. 1990;85:144-151.
25. Connor WE, Connor SL. Should a low-fat, high-carbohydrate diet be recommended for everyone? the case for a low-fat, high-carbohydrate diet. N Engl J Med. 1997;337:562-563, 566.
26. King SB III, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery: Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med. 1994; 331:1044-1050.
27. Ornish D. Dietary treatment of hyperlipidemia. J Cardiocasc Risk. 1994;1:283-286.
28. Morrison LM. Diet in coronary atherosclerosis. JAMA. 1960;173:884-888.
29. Esselstyn CB Jr, Ellis SG, Medendorp SV, Crowe TD. A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician's practice. J Fam Pract. 1995;41: 560-568.
30. Ornish D. Avoiding revascularization with life-style changes: The Multicenter Lifestyle Demonstration Project. Am J Cardiol. 1998;82:72T-76T.
31. Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications. JAMA. 1998; 279:1458-1462.
32. Newman TB, Hulley SB. Carcinogenicity of lipid-lowering drugs. JAMA 1996 75:55-60.